Medivolve Stock Analysis

Medivolve Pink Sheet Analysis Notes

About 12.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.76. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Medivolve had not issued any dividends in recent years. The entity had 1:10 split on the 23rd of October 2015. It is a social-impact investment focused company Investing resources, funds and bandwidth for the betterment of the human condition through medical sciences, climate change and technology. Copper One Inc. was incorporated in 2005 and is headquartered in Toronto, Canada. Medivolve operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 210 people.The quote for Medivolve is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. To find out more about Medivolve contact David Preiner at 416-861-2267 or learn more at https://www.medivolve.ca.

Medivolve Investment Alerts

Medivolve Market Capitalization

The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.51 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medivolve's market, we take the total number of its shares issued and multiply it by Medivolve's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.

Medivolve Profitablity

The company has Profit Margin (PM) of (0.11) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.01 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.01.

Technical Drivers

In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Medivolve, as well as the relationship between them.

Medivolve Price Movement Analysis

Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how Medivolve prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Medivolve shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as Medivolve. By using and applying Medivolve Pink Sheet analysis, traders can create a robust methodology for identifying Medivolve entry and exit points for their positions.

When running Medivolve's price analysis, check to measure Medivolve's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medivolve is operating at the current time. Most of Medivolve's value examination focuses on studying past and present price action to predict the probability of Medivolve's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medivolve's price. Additionally, you may evaluate how the addition of Medivolve to your portfolios can decrease your overall portfolio volatility.